MRI 유도 신경외과적 절제술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The MRI Guided Neurosurgical Ablation Market size is expected to reach USD 1570.17 Billion in 2034 from USD 776.37 Billion (2025) growing at a CAGR of 8.14% during 2026-2034.

The global MRI-guided neurosurgical ablation market is set to experience substantial growth, driven by the increasing prevalence of neurological disorders and the rising demand for minimally invasive surgical techniques. MRI-guided neurosurgical ablation offers a precise and effective approach to treating conditions such as tumors, epilepsy, and chronic pain by utilizing magnetic resonance imaging to guide the ablation process. This technology not only enhances the accuracy of the procedure but also minimizes damage to surrounding healthy tissue, leading to improved patient outcomes and faster recovery times. As healthcare providers seek to adopt advanced treatment modalities, the demand for MRI-guided neurosurgical ablation is expected to rise significantly.

Moreover, advancements in MRI technology and ablation techniques are anticipated to further boost the market. The development of high-field MRI systems and innovative ablation devices is enhancing the capabilities of neurosurgeons, allowing for more complex procedures to be performed with greater precision. Additionally, the integration of real-time imaging and navigation systems is improving the safety and efficacy of neurosurgical interventions. As research continues to uncover new applications for MRI-guided ablation, the market is likely to witness an influx of innovative solutions that cater to the evolving needs of patients and healthcare providers.

In addition, the growing emphasis on patient-centric care and the increasing focus on reducing healthcare costs are expected to shape the future of the MRI-guided neurosurgical ablation market. As patients become more informed about their treatment options, there is a rising demand for procedures that offer minimal invasiveness and shorter hospital stays. MRI-guided neurosurgical ablation aligns with these preferences, providing effective treatment options that enhance patient satisfaction. Collaborative efforts between medical device manufacturers, healthcare providers, and regulatory bodies will be essential in driving these innovations, ensuring that the MRI-guided neurosurgical ablation market remains responsive to the evolving landscape of neurosurgery and patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• MRI Guided RF Ablation Systems
• MRI Guided Laser Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

By End Use

• Hospitals
• Clinics
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Siemens Healthineers AG, Monteri, Profound Medical, Insightec, Medtronic, Boston Scientific Corporation, AngioDynamics, ClearPoint Neuro Inc, Elekta, Accuray Incorporated

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. MRI Guided RF Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. MRI Guided Laser Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. MRI Guided Focused Ultrasound Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MRI GUIDED NEUROSURGICAL ABLATION INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Siemens Healthineers AG
  • 8.2.2 Monteri
  • 8.2.3 Profound Medical
  • 8.2.4 Insightec
  • 8.2.5 Medtronic
  • 8.2.6 Boston Scientific Corporation
  • 8.2.7 AngioDynamics
  • 8.2.8 ClearPoint Neuro Inc
  • 8.2.9 Elekta
  • 8.2.10 Accuray Incorporated